NL267508A - - Google Patents

Info

Publication number: NL267508A
Authority: NL; Netherlands

Application number

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1960-07-26

Publication of NL267508A publication Critical patent/NL267508A/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)

NL267508D 1960-07-26 NL267508A (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US4529260A	1960-07-26	1960-07-26
US118261A US3176019A (en)	1960-07-26	1961-06-20	Substituted aminobutynyl acetates

Publications (1)

Publication Number	Publication Date
NL267508A true NL267508A (es)

Family

ID=26722613

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NL267508D NL267508A (es)	1960-07-26
NL124473D NL124473C (es)	1960-07-26

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
NL124473D NL124473C (es)	1960-07-26

Country Status (9)

Country	Link
US (1)	US3176019A (es)
BE (1)	BE606560A (es)
CH (1)	CH421078A (es)
DE (1)	DE1216866B (es)
DK (1)	DK113854B (es)
ES (1)	ES269353A1 (es)
FR (1)	FR1325M (es)
GB (1)	GB940540A (es)
NL (2)	NL124473C (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5736577A (en) *	1995-01-31	1998-04-07	Sepracor, Inc.	Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
US3864388A (en) *	1970-12-29	1975-02-04	Sumitomo Chemical Co	Alkynyl esters of {60 -alkoxy-{60 -phenyl alkenoic acid
US5036107A (en) *	1986-06-27	1991-07-30	Marion Merrell Dow Inc.	1,7-substituted heptyn-2-ones and use
US4957941A (en) *	1987-11-16	1990-09-18	United Pharmaceuticals, Inc.	Anti-spasmdoic agents having an acetylenic bond
IL91377A (en) *	1988-09-14	1996-09-12	Nippon Shinyaku Co Ltd	Derivatives of botinylamine glycolate
US5532278A (en) *	1995-01-31	1996-07-02	Sepracor, Inc.	Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
US5677346A (en) *	1995-01-31	1997-10-14	Sepracor, Inc.	Treating urinary incontinence using (S)-desethyloxybutynin
WO1998001125A2 (en) *	1996-07-09	1998-01-15	Sepracor, Inc.	Dextrorotatory isomers of oxybutynin and desethyloxybutynin in the treatment of gastrointestinal hyperactivity
US5973182A (en) *	1998-10-22	1999-10-26	Sepracor Inc.	Carbonate Intermediates useful in the preparation of optically active cyclohexylphenylglycolate esters
US6140529A (en) *	1998-10-22	2000-10-31	Sepracor Inc.	Synthesis of optically active cyclohexylphenylglycolate esters
US7179483B2 (en)	2000-04-26	2007-02-20	Watson Pharmaceuticals, Inc.	Compositions and methods for transdermal oxybutynin therapy
CN102327253A (zh) *	2000-04-26	2012-01-25	沃特森药物公司	最小化与奥昔布宁疗法有关的副作用
WO2003035599A1 (en)	2001-10-26	2003-05-01	Pharmacia & Upjohn Company	Quarternary ammonium compounds and their use as antimuscarinic agents
MXPA05000434A (es)	2002-07-08	2005-04-19	Ranbaxy Lab Ltd	Derivados de hexano [3.1.0] azabiciclo 3,6-disustituido utiles como antagonistas de receptor muscarinico.
WO2004014853A1 (en) *	2002-07-31	2004-02-19	Ranbaxy Laboratories Limited	3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
EP1545508A4 (en) *	2002-08-09	2009-11-25	Ranbaxy Lab Ltd	3,6-DISUBSTITUTED AZABICYCLO ¬3.1.0 HEXANE DERIVATIVES AS USEFUL AS MUSCARINIC RECEPTOR AGONISTS
EP1534675B1 (en) *	2002-08-23	2009-02-25	Ranbaxy Laboratories, Ltd.	Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo¬3.1.0 hexane derivatives as muscarinic receptor antagonists
TW200412945A (en)	2002-10-25	2004-08-01	Upjohn Co	Quaternary ammonium compounds
EP1572648B1 (en)	2002-12-10	2008-07-09	Ranbaxy Laboratories, Ltd.	3,6-disubstituted azabicyclo (3.1.0)-hexane derivatives as muscarinic receptor antagonists
ATE386738T1 (de) *	2002-12-23	2008-03-15	Ranbaxy Lab Ltd	Flavaxat-derivate als muscarin-rezeptor antagonisten
AU2002347552A1 (en) *	2002-12-23	2004-07-14	Ranbaxy Laboratories Limited	1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists
US7488748B2 (en)	2003-01-28	2009-02-10	Ranbaxy Laboratories Limited	3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
WO2004089898A1 (en) *	2003-04-09	2004-10-21	Ranbaxy Laboratories Limited	Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
ATE362364T1 (de) *	2003-04-10	2007-06-15	Ranbaxy Lab Ltd	Substituierte azabicyclo hexane derivate als muscarin rezeptor antagonisten
WO2004089899A1 (en)	2003-04-10	2004-10-21	Ranbaxy Laboratories Limited	Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
CN100436414C (zh) *	2003-04-11	2008-11-26	兰贝克赛实验室有限公司	作为毒蕈碱受体拮抗剂的氮杂双环衍生物
ATE419246T1 (de) *	2004-06-16	2009-01-15	Ranbaxy Lab Ltd	Als antagonisten des muscarinrezeptors geeignete xanthinderivate
EP1781607A2 (en) *	2004-08-19	2007-05-09	Ranbaxy Laboratories Limited	Pyrrolidine derivatives as muscarinic receptor antagonists
US20080280883A1 (en) *	2004-09-24	2008-11-13	Mohammad Salman	Muscarinic Receptor Antagonists
US20090105221A1 (en) *	2004-09-29	2009-04-23	Ranbaxy Laboratories Limited	Muscarinic receptor antagonists
EP1828174A1 (en) *	2004-11-19	2007-09-05	Ranbaxy Laboratories Limited	Azabicyclic muscarinic receptor antagonists
WO2006064304A1 (en) *	2004-12-15	2006-06-22	Ranbaxy Laboratories Limited	Acid addition salts of muscarinic receptor antagonists
WO2006117754A1 (en) *	2005-05-03	2006-11-09	Ranbaxy Laboratories Limited	3,6-disubstituted azabicyclo [3.1.0] hexane derivatives as muscarinic receptor antagonists
CA2626612A1 (en)	2005-10-19	2007-04-26	Ranbaxy Laboratories Limited	Pharmaceutical compositions of muscarinic receptor antagonists
US20090010923A1 (en) *	2007-04-24	2009-01-08	University Of Maryland, Baltimore	Treatment of cancer with anti-muscarinic receptor agents
WO2009122429A2 (en) *	2008-02-04	2009-10-08	Matrix Laboratories Limited	Crystalline oxybutynin and process for preparing the same
US8748433B2 (en)	2010-04-30	2014-06-10	Merck Sharp & Dohme Corp.	β3 adrenergic receptor agonists
US9907767B2 (en)	2010-08-03	2018-03-06	Velicept Therapeutics, Inc.	Pharmaceutical compositions and the treatment of overactive bladder
BR112013002511A2 (pt)	2010-08-03	2017-06-27	Altherx Inc	combinações de agonistas de receptores adrenérgicos beta - 3 e antagonistas receptores muscarínicos para tratamento da bexica hiperativa
AU2013216864A1 (en)	2012-02-09	2014-09-11	Altherx, Inc.	Combination of muscarinic receptor antagonists and beta- 3 adrenoceptor agonists for treating overactive bladder
KR20170086659A (ko)	2014-12-03	2017-07-26	벨리셉트 테라퓨틱스, 인크.	하부 요로 증상을 위한 변형 방출형 솔라베그론을 이용한 조성물 및 방법
CN108290824B (zh)	2015-10-23	2022-03-11	B3Ar治疗股份有限公司	索拉贝隆两性离子及其应用
AU2019214891A1 (en)	2018-01-30	2020-08-20	Apnimed, Inc. (Delaware)	Methods and compositions for treating sleep apnea

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE895595C (de) *	1943-09-29	1953-11-05	Basf Ag	Verfahren zur Herstellung von Aminoalkinolen
DE1003209B (de) *	1953-03-24	1957-02-28	Basf Ag	Verfahren zur Herstellung spasmolytisch wirksamer basischer Carbinole
US2867619A (en) *	1956-11-05	1959-01-06	Lakeside Lab Inc	Aminoalkynyl-n-alkylpiperidine carboxylates
DE1083254B (de) *	1957-04-01	1960-06-15	Lakeside Lab In	Verfahren zur Herstellung von blutdrucksenkenden N-disubstituierten Diaminoalkinen, deren Saeureadditionssalzen oder quaternaeren Ammoniumsalzen
DE1100617B (de) *	1959-10-22	1961-03-02	Basf Ag	Verfahren zur Herstellung von 1-Dialkylamino-4-hydroxy-acetylenen-(2)

0
- NL NL267508D patent/NL267508A/xx unknown
- NL NL124473D patent/NL124473C/xx active
1961
- 1961-06-20 US US118261A patent/US3176019A/en not_active Expired - Lifetime
- 1961-07-19 DE DEM49737A patent/DE1216866B/de active Pending
- 1961-07-20 FR FR868440A patent/FR1325M/fr active Active
- 1961-07-20 CH CH856161A patent/CH421078A/de unknown
- 1961-07-24 ES ES0269353A patent/ES269353A1/es not_active Expired
- 1961-07-25 DK DK304861AA patent/DK113854B/da unknown
- 1961-07-25 GB GB26864/61A patent/GB940540A/en not_active Expired
- 1961-07-26 BE BE606560A patent/BE606560A/fr unknown

Also Published As

Publication number	Publication date
NL124473C (es)
GB940540A (en)	1963-10-30
ES269353A1 (es)	1961-11-16
FR1325M (fr)	1962-05-21
DK113854B (da)	1969-05-05
US3176019A (en)	1965-03-30
BE606560A (fr)	1962-01-26
DE1216866B (de)	1966-05-18
CH421078A (de)	1966-09-30

Publication	Publication Date	Title
BE604029A (es)	1961-06-15
DE1302648B (es)
DE1134594C2 (es)	1963-02-21
FI42783B (es)	1970-06-30
DE1234064C2 (es)	1967-08-24
BE601704A (es)	1961-09-25
FI44094B (es)	1971-04-30
FR1220538A (es)	1960-05-25
FI40014B (es)	1968-05-31
FI40498B (es)	1968-10-31
FI40960B (es)	1969-03-31
DE1167984C2 (es)	1964-10-29
FI40640B (es)	1968-12-31
DE1440270A1 (es)	1972-11-09
BE643308A (es)	1964-05-29
BE610871A (es)
BE693652A (es)	1967-07-17
BE608466A (es)
BE608878A (es)
BE608961A (es)
BE609410A (es)
BE610141A (es)
BE610152A (es)
BE606040A (es)
BE605795A (es)